COVID-19 treatments and clinical trials
DHSC publications relating to COVID-19 treatments and clinical trials.
This collection brings together publications from the Department of Health and Social Care (DHSC) relating to coronavirus (COVID-19) treatments and clinical trials.
For more information, see:
- treatments for COVID-19 on the NHS website
- COVID-19 Therapeutics Clinical Review Panel
Expert advice
Treatments
Clinical trials
Published 6 September 2022
Last updated 3125 MarchMay 2023
+ show all updates
-
Added 'Higher-risk patients eligible for COVID-19 treatments: independent advisory group report (March 2023)' to the expert advice section.
-
Renamed and updated document collection to reflect the closure of the Antivirals and Therapeutics Taskforce on 31 March 2023.
-
Added information under 'Protection' including a link to the Evusheld evaluation.
-
Added new 'Protection' section containing links to pages on the RAPID C-19 Oversight Group report into Evusheld and letter to patient groups on the decision not to procure Evusheld.
-
First published.
Clinical trials
Published 6 September 2022
Last updated 3125 MarchMay 2023
+ show all updates
-
Added 'Higher-risk patients eligible for COVID-19 treatments: independent advisory group report (March 2023)' to the expert advice section.
-
Renamed and updated document collection to reflect the closure of the Antivirals and Therapeutics Taskforce on 31 March 2023.
-
Added information under 'Protection' including a link to the Evusheld evaluation.
-
Added new 'Protection' section containing links to pages on the RAPID C-19 Oversight Group report into Evusheld and letter to patient groups on the decision not to procure Evusheld.
-
First published.
Last updated
-
Added 'Higher-risk patients eligible for COVID-19 treatments: independent advisory group report (March 2023)' to the expert advice section.
-
Renamed and updated document collection to reflect the closure of the Antivirals and Therapeutics Taskforce on 31 March 2023.
-
Added information under 'Protection' including a link to the Evusheld evaluation.
-
Added new 'Protection' section containing links to pages on the RAPID C-19 Oversight Group report into Evusheld and letter to patient groups on the decision not to procure Evusheld.
-
First published.
Update history
2023-05-25 14:10
Added ‘Higher-risk patients eligible for COVID-19 treatments: independent advisory group report (March 2023)’ to the expert advice section.
2023-03-31 14:14
Renamed and updated document collection to reflect the closure of the Antivirals and Therapeutics Taskforce on 31 March 2023.
2022-12-14 15:15
Added information under ‘Protection’ including a link to the Evusheld evaluation.
2022-10-06 14:00
Added new ‘Protection’ section containing links to pages on the RAPID C-19 Oversight Group report into Evusheld and letter to patient groups on the decision not to procure Evusheld.
2022-09-06 12:22
First published.